Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025-2

SGLT2 inhibition,circulating biomarkers,and Alzheimer's disease: A Mendelian randomization study

Hao Yang, Yuye Ning, Meilin Chen [...]

Journal of Alzheimer’s Disease

Open access

Brief report

First published 2022-9

Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis

Elisabeth B Stougaard, Peter L Kristensen, Urd Kielgast [...]

Diabetes & Vascular Disease Research

Open access

Research article

First published 2025

Sodium-glucose cotransporter-1 inhibition and depression: A Mendelian randomization study

Gang Fan, Hong Zuo, Xun Shi [...]

Sage Open Medicine

Free access

Review article

First published 2018-9

Effects of sodium glucose co-transporter 2 inhibitors on the kidney

Natalia de Albuquerque Rocha, Ian J Neeland, Peter A McCullough [...]

Diabetes & Vascular Disease Research

Open access

Case report

First published 2017-4

Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin

Daniel A. Kelmenson, Kelsey Burr, Yusra Azhar [...]

Journal of Investigative Medicine High Impact Case Reports

Free access

Brief report

First published 2016-11

Tofogliflozin,a selective inhibitor of sodium-glucose cotransporter 2,suppresses renal damage in KKAy/Ta mice,obese and type 2 diabetic animals

Yuji Ishibashi, Takanori Matsui, Sho-ichi Yamagishi

Diabetes & Vascular Disease Research

Open access

Research article

First published 2018-06

Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care

Thomas Danne, Torben Biester, Olga Kordonouri

Diabetes Technology & Therapeutics

Free access

Review article

First published 2014-12

Dapagliflozin efficacy and safety: a perspective review

Sarah L. Anderson

Therapeutic Advances in Drug Safety

Open access

Review article

First published 2025-03

Comparison Between SGLT2 Inhibitors and Lactation: Implications for Cardiometabolic Health in Parous Women

Maria A. Ramos-Roman

Metabolic Syndrome and Related Disorders

Open access

Research article

First published 2019

How and why SGLT2 inhibitors should be explored as potential treatment option in diabetic retinopathy: clinical concept and methodology

Marcus May, Theodor Framke, Bernd Junker [...]

Therapeutic Advances in Endocrinology and Metabolism

Search results